Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 1/20 | 0.49 |
| ▸ | CA1 | P00915 | 1/20 | 0.49 |
| ▸ | CA2 | P00918 | 1/20 | 0.49 |
| ▸ | CA7 | P43166 | 1/20 | 0.49 |
| ▸ | CA9 | Q16790 | 1/20 | 0.49 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.49 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
| ▸ | CTSD | P07339 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5997281 | 0.93 | TAS1R3 (0.44) | CA12CA1CA2CA7CA9 | |
| SCHEMBL5997530 | 0.92 | CA12 (0.41) | CA12CA1CA2CA7CA9 | |
| SCHEMBL5996427 | 0.92 | MAPT (0.46) | CA12CA1CA2CA7CA9 | |
| SCHEMBL5995950 | 0.92 | CA12 (0.41) | CA12CA1CA2CA7CA9 | |
| SCHEMBL5995758 | 0.92 | SMN1; SMN2 (0.47) | CA12CA1CA2CA7CA9 | |
| SCHEMBL5996356 | 0.92 | PPARA (0.42) | CA12CA1CA2CA7CA9 | |
| SCHEMBL5995341 | 0.89 | CA12 (0.40) | CA12CA1CA2CA7CA9 | |
| SCHEMBL5997707 | 0.88 | KDM4E (0.40) | CA12CA1CA2CA7CA9 | |
| SCHEMBL5993570 | 0.88 | CA12 (0.39) | CA12CA1CA2CA7CA9 | |
| SCHEMBL5996528 | 0.87 | CA12 (0.49) | CA12CA1CA2CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 290 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2586804-A2 | Photoradically and thermally radically curable composition | KANEKA CORPORATION (JP) | 2013-05-01 | — | — | EP | claimed |
| CN-122080333-A | Curable composition, heat storage material, and article | — | 2026-05-26 | — | — | CN | disclosed |
| WO-2026105802-A1 | RESIN COMPOSITION, DRY FILM, AND CURED PRODUCT | 太陽ホールディングス株式会社 | 2026-05-21 | — | — | WO | disclosed |
| US-12624140-B2 | Composition containing compound having polyoxyalkylene chain | RESONAC CORPORATION (JP) | 2026-05-12 | — | — | US | disclosed |
| CN-122011299-A | Curable composition, heat storage material, and article | 株式会社力森诺科 | 2026-05-12 | — | — | CN | disclosed |
| EP-4711396-A1 | CURABLE COMPOSITION | Tokyo University of Science (JP) | 2026-03-18 | — | — | EP | disclosed |
| US-20260060900-A1 | DENTAL COMPOSITE RESIN KIT | SHOFU INC. (JP) | 2026-03-05 | — | — | US | disclosed |
| US-12492275-B2 | Photo-curable compositions containing high refractive index monomers for use in 3D printing applications | ARKEMA FRANCE (FR) | 2025-12-09 | — | — | US | disclosed |
| US-20250346702-A1 | COMPOSITION THAT CONTAINS COMPOUND HAVING POLYOXYALKYLENE CHAIN AND ACRYLIC COPOLYMER | RESONAC CORP (JP) | 2025-11-13 | — | — | US | disclosed |
| US-20250304748-A1 | RESIN COMPOSITION, DRY FILM, AND CURED PRODUCT | TAIYO HOLDINGS CO., LTD. (JP) | 2025-10-02 | — | — | US | disclosed |
| US-20100222446-A1 | CURABLE COMPOSITION FOR BOTH PHOTORADICAL CURING AND THERMAL RADICAL CURING | KANEKA CORPORATION (JP) | 2010-09-02 | — | — | US | disclosed |
| US-20100196704-A1 | COMPOSITE FILM | NITTO DENKO CORPORATION (JP) | 2010-08-05 | — | — | US | disclosed |
| EP-2186849-A1 | COMPOSITE FILM | Nitto Denko Corporation (JP) | 2010-05-19 | — | — | EP | disclosed |
| US-20090192238-A1 | Active Energy Ray-Curable Composition And Cured Product Thereof | KANEKA CORPORATION (JP) | 2009-07-30 | — | — | US | disclosed |
| EP-1967533-A1 | PHOTORADICALLY AND THERMALLY RADICALLY CURABLE COMPOSITION | Kaneka Corporation (JP) | 2008-09-10 | — | — | EP | disclosed |
| EP-1837352-A1 | ACTIVE ENERGY RAY-CURABLE COMPOSITION AND CURED PRODUCT THEREOF | Kaneka Corporation (JP) | 2007-09-26 | — | — | EP | disclosed |
| US-6486228-B2 | BIS-ACYLPHOSPHINE OXIDES AND ACYLPHOSPHINE OXIDES FOR CURING PHOTOPOLYMERIZABLE COMPOSITIONS WITHOUT YELLOWING; USE IN WHITE SURFACE COATINGS, AS NEGATIVE PHOTORESISTS, IN PRINTING PLATES | CIBA SPECIALTY CHEMICALS CORPORATION | 2002-11-26 | — | — | US | disclosed |
| US-20010036978-A1 | Photoinitiator combinations | IGM GROUP B.V. (NL) | 2001-11-01 | — | — | US | disclosed |
| US-6251963-B1 | ORGAOPHOSPHOROUS COMPOUND CONTAINING KETONE GROUP | CIBA SPECIALTY CHEMICALS CORPORATION | 2001-06-26 | — | — | US | disclosed |
| US-5942290-A | MOLECULAR COMPLEX OF A MONO-, BIS- OR TRIACYLPHOSPHINE OXIDE ASSOCIATED WITH AN ALPHA-HYDROXY KETONE IN CRYSTALLINE FORM BY WAY OF HYDROGEN BONDING; PHOTOGRAPHIC PRODUCTION OF RELIEF IMAGES | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 1999-08-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260060900-A1 | DENTAL COMPOSITE RESIN KIT | BOLA2; BOLA2B, LBR, COL2A1 | CA12 3232/4885CA1 1024/4885CA2 959/4885 |
| US-12624140-B2 | Composition containing compound having polyoxyalkylene chain | PIEZO1, HVCN1, TAF11 | CA12 1423/4885CA1 2595/4885CA2 2137/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.